Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Narcolepsy

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.

Anxiolytic Drugs: Overview

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

Cardiopulmonary Resuscitation IV: Pharmacological Management

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Slow-Wave Sleep Fragmentation in Disorders of Arousal and Sleep-Related Hypermotor Epilepsy: A Multicenter Polysomnographic Study.

Neurology·2026

Same author

A dimensional approach to hypersomnolence disorder without comorbidity: results from a French preliminary study and data visualization.

Neurophysiologie clinique = Clinical neurophysiology·2026

Same author

The hidden burden of narcolepsy type 1: Discordance in psychobehavioral symptoms between patient self-reports and reports from close family members and friends.

Sleep medicine·2026

Same author

Investigation of the "Not Better Explained" Diagnosis Criteria in Sleep Disorder Classifications: A Systematic Content Analysis and Critical Review.

Journal of sleep research·2026

Same author

Is a change in mouth opening associated with improvements in quality of life in children with type 1 obstructive sleep apnoea after adenotonsillectomy? Protocol for the JawChild prospective cohort study.

BMJ open·2025

Same author

STARDEV Study: Neurodevelopmental Trajectory and Long-Term Outcomes of Patients with Startle Disease/Hyperekplexia.

Movement disorders clinical practice·2025

Search research articles

Related Experiment Video

Updated: May 13, 2026

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Pharmacotherapy options for cataplexy.

Régis Lopez¹, Yves Dauvilliers

¹Gui-de-Chauliac Hospital, National Reference Network for Narcolepsy, Sleep-Wake Disorders Center, Department of Neurology, CHU Montpellier, INSERM U1061, 80 avenue Augustin Fliche, 34295 Montpellier cedex 5, France.

Expert Opinion on Pharmacotherapy

|March 26, 2013

Summary

Sodium oxybate is the first-line treatment for cataplexy, a symptom of narcolepsy. Antidepressants like venlafaxine are second-line options, with future therapies targeting immune responses and hypocretin.

More Related Videos

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

Related Experiment Videos

Last Updated: May 13, 2026

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

An Automated Squint Method for Time-syncing Behavior and Brain Dynamics in Mouse Pain Studies

Published on: November 1, 2024

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

Area of Science:

Neurology
Sleep Medicine
Pharmacology

Background:

Narcolepsy with cataplexy is a rare, disabling sleep disorder.
Key symptoms include excessive daytime sleepiness and cataplexy.
The condition results from the loss of hypothalamic hypocretin neurons.

Purpose of the Study:

To review current evidence on the optimal management of cataplexy.
To analyze the evolution of cataplexy treatment strategies.

Main Methods:

Literature search on PubMed using keywords: narcolepsy, cataplexy, treatment, medication, drug.
Critical analysis and review of current evidence on human cataplexy management.

Main Results:

Sodium oxybate is identified as the first-line pharmacological treatment based on Class 1 evidence.
Antidepressants, particularly venlafaxine, are considered second-line treatments.
Current recommendations for second-line treatments lack Class 1 evidence and rely on expert opinion.

Conclusions:

Sodium oxybate is the recommended first-line treatment for cataplexy.
Venlafaxine offers a potential second-line option due to its benefit-risk profile.
Future therapeutic targets include immune-based therapies and hypocretin replacement.